Yu, Jianhua

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

Benson, D. M., Bakan, C. E., Mishra, A., Hofmeister, C. C., Efebera, Y., Becknell, B., Baiocchi, R. A., Zhang, J., Yu, J., Smith, M. K., et al. (2010) · Blood

Immune Cell Function and InteractionMultiple Myeloma Research and Treatments

Cited by 807

CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma

Chu, J., Deng, Y., Benson, D. M., He, S., Hughes, T., Zhang, J., Peng, Y., Mao, H., Yi, L., Ghoshal, K., et al. (2014) · Leukemia

CAR-T cell therapy researchImmune Cell Function and Interaction

Cited by 439

Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells

Srivastava, A. K., Han, C., Zhao, R., Cui, T., Dai, Y., Mao, C., Zhao, W., Zhang, X., Yu, J., & Wang, Q.-E. (2015) · Proceedings of the National Academy of Sciences

Cancer Cells and MetastasisOvarian cancer diagnosis and treatment

Cited by 188

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy

Yilmaz, A., Cui, H., Caligiuri, M. A., & Yu, J. (2020) · Journal of Hematology & Oncology

CAR-T cell therapy researchImmune Cell Function and Interaction

Cited by 171

Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts

Vasu, S., He, S., Cheney, C., Gopalakrishnan, B., Mani, R., Lozanski, G., Mo, X., Groh, V., Whitman, S. P., Konopitzky, R., et al. (2016) · Blood

Acute Myeloid Leukemia ResearchImmune Cell Function and Interaction

Cited by 93